Halozyme Therapeutics Inc.

NASDAQ:HALO   2:17:05 PM EDT
57.56
-0.29 (-0.50%)
Other Pre-Announcement

Halozyme Reports Third Quarter 2022 Financial, Operating Results

Published: 11/08/2022 21:29 GMT
Halozyme Therapeutics Inc. (HALO) - Halozyme Reports Third Quarter 2022 Financial and Operating Results.
Q3 Revenue Rose 80 Percent to $209.0 Million.
Q3 GAAP Earnings per Share $0.44.
Q3 Non-GAAP Earnings per Share $0.74.
Q3 Earnings per Share View $0.51, Revenue View $191.1 Million -- Refinitiv Ibes Data (analyst estimates).
Co is Reiterating Its Financial Guidance for 2022.